Efficacy of endoscopic retrograde cholangiopancreatography combined with SpyGlass system in treatment of acute cholecystitis secondary to choledocholithiasis

Liying TAO; Hongguang WANG; Xiang GUO; Jian ZHOU; Qingmei GUO; Mantong WANG

doi:10.3969/j.issn.1001-5256.2022.08.025

Volume 38 Issue 8

Aug. 2022

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(8): 1854-1858

PDF( 2754 KB)

Efficacy of endoscopic retrograde cholangiopancreatography combined with SpyGlass system in treatment of acute cholecystitis secondary to choledocholithiasis

DOI: 10.3969/j.issn.1001-5256.2022.08.025

Department of Gastroenterology, Jilin City People's Hospital, Jilin, Jilin 132001, China

Research funding:

Jilin City Medical and Health Guidance Program (20210409008);

Jilin Provincial Health Science and Technology Capacity Building Program (2021LC120)

More Information

Corresponding author: GUO Xiang, 18223115@qq.com(ORCID: 0000-0003-0090-7772)
Received Date: 2021-12-06
Accepted Date: 2022-01-10
Published Date: 2022-08-20

Abstract

Abstract

Objective To investigate the efficacy and safety of endoscopic retrograde cholangiopancreatography (ERCP)+SpyGlass system versus percutaneous transhepatic gallbladder drainage (PTGD)+ERCP in the treatment of acute cholecystitis secondary to choledocholithiasis. Methods A retrospective analysis was performed for the clinical data of the patients with acute cholecystitis secondary to choledocholithiasis who were treated in Department of Gastroenterology, Jilin City People's Hospital, from December 2019 to September 2021, among whom there were 23 patients in the ERCP+SpyGlass group and 19 patients in the PTGD+ERCP group. The two groups were compared in terms of the indicators such as surgical technical success, surgical operation time, surgical clinical success, postoperative recovery, length of hospital stay, and complications. The two-independent-samples t test was used for comparison of normally distributed continuous data between groups, and the Wilcoxon rank-sum test was used for comparison of non-normally distributed continuous data between groups; the chi- square test or the Fisher's exact test was used for comparison of categorical data between groups. Results Compared with the PTGD+ERCP group, the ERCP+SpyGlass group had a significant reduction in C-reactive protein after surgery (Z=2.999, P=0.003). There were no significant differences between the two groups in technical success rate (χ²=1.735, P=0.188), clinical success rate (χ²=0.846, P=0.358), total time of operation (t=1.667, P= 0.113), white blood cell count on day 1 after surgery (t=1.075, P= 0.289), length of postoperative hospital stay (t=1.560, P=0.127), and incidence rate of complications (all P > 0.05). Conclusion In the treatment of acute cholecystitis secondary to choledocholithiasis, the ERCP+SpyGlass system has a comparable clinical effect to PTGD+ERCP and is safe and effective, without increasing surgery-related adverse events and risks, and it can also solve the problems of the biliary tract and the gallbladder at one time through natural orifices, with no scars on body surface and convenient postoperative nursing. Therefore, it holds promise for clinical application.
- Choledocholithiasis,
- Cholecystitis, Acute,
- Cholangiopancreatography, Endoscopic Retrograde,
- SpyGlass System

FullText(HTML)

References(20)

References

[1]	HAN JZ, TUO HF, WANG ZP, et al. Research advances in percutaneous cholecystostomy in treatment of acute cholecystitis[J]. J Clin Hepatol, 2021, 37(8): 1983-1987. DOI: 10.3969/j.issn.1001-5256.2021.08.052. 韩景钊, 脱红芳, 王泽普, 等. 经皮胆囊造瘘术治疗急性胆囊炎的研究进展[J]. 临床肝胆病杂志, 2021, 37(8): 1983-1987. DOI: 10.3969/j.issn.1001-5256.2021.08.052.
[2]	LIN S. Effect of percutaneous transhepatic gallbladder drainage on inflammatory mediators and complications in patients with acute cholecystitis[J]. Pract Clin J Integr Tradit Chin Western Med, 2021, 21(11): 130-131. DOI: 10.13638/j.issn.1671-4040.2021.11.065. 林生. 经皮经肝胆囊穿刺引流术对急性胆囊炎患者炎症介质及并发症的影响[J]. 实用中西医结合临床, 2021, 21(11): 130-131. DOI: 10.13638/j.issn.1671-4040.2021.11.065.
[3]	NASIM S, KHAN S, ALVI R, et al. Emerging indications for percutaneous cholecystostomy for the management of acute cholecystitis-a retrospective review[J]. Int J Surg, 2011, 9(6): 456-459. DOI: 10.1016/j.ijsu.2011.04.008.
[4]	KURIHARA T, YASUDA I, ISAYAMA H, et al. Diagnostic and therapeutic single-operator cholangiopancreatoscopy in biliopancreatic diseases: Prospective multicenter study in Japan[J]. World J Gastroenterol, 2016, 22(5): 1891-1901. DOI: 10.3748/wjg.v22.i5.1891.
[5]	BOKEMEYER A, GERGES C, LANG D, et al. Digital single-operator video cholangioscopy in treating refractory biliary stones: a multicenter observational study[J]. Surg Endosc, 2020, 34(5): 1914-1922. DOI: 10.1007/s00464-019-06962-0.
[6]	LIU SZ, TIAN YZ. Minimally invasive surgical treatment of common bile duct stones[J/CD]. Chin J Hepat Surg(Electronic Edition, 2020), 9(4): 313-316. DOI: 10.3877/cma.j.issn.2095-3232.2020.04.004. 刘世洲, 田彦璋. 胆总管结石微创外科治疗[J/CD]. 中华肝脏外科手术学电子杂志, 2020, 9(4): 313-316. DOI: 10.3877/cma.j.issn.2095-3232.2020.04.004.
[7]	CHOK KS, CHU FS, CHEUNG TT, et al. Results of percutaneous transhepatic cholecystostomy for high surgical risk patients with acute cholecystitis[J]. ANZ J Surg, 2010, 80(4): 280-283. DOI: 10.1111/j.1445-2197.2009.05105.x.
[8]	XIE J, YU YQ, WANG HJ, et al. Clinical efficacy of PTGD in the treatment of senile acute cholecystitis[J]. Chin J Gerontol, 2021, 41(17): 3668-3670. DOI: 10.3969/j.issn.1005-9202.2021.17.012. 谢军, 余永强, 王洪剑, 等. PTGD治疗老年急性胆囊炎的临床疗效[J]. 中国老年学杂志, 2021, 41(17): 3668-3670. DOI: 10.3969/j.issn.1005-9202.2021.17.012.
[9]	MASRANI A, YOUNG D, KARAGEORGIOU JP, et al. Management algorithm of acute cholecystitis after percutaneous cholecystostomy catheter placement based on outcomes from 377 patients[J]. Abdom Radiol (NY), 2020, 45(4): 1193-1197. DOI: 10.1007/s00261-020-02449-y.
[10]	STORM AC, VARGAS EJ, CHIN JY, et al. Transpapillary gallbladder stent placement for long-term therapy of acute cholecystitis[J]. Gastrointest Endosc, 2021, 94(4): 742-748. e1. DOI: 10.1016/j.gie.2021.03.025.
[11]	GAO DJ, HU B, YE X, et al. Endoscopic retrograde catheterization of gallbladder and transpapillary gallbladder stenting for gallbladder diseases[J]. Chin J Dig Endosc, 2017, 34(4): 238-242. DOI: 10.3760/cma.j.issn.1007-5232.2017.04.003. 高道键, 胡冰, 叶馨, 等. 内镜下逆行胆囊管超选技术及胆囊塑料支架置入术在胆囊疾病中的初步应用[J]. 中华消化内镜杂志, 2017, 34(4): 238-242. DOI: 10.3760/cma.j.issn.1007-5232.2017.04.003.
[12]	XU W, MIAO L, WANG ZF, et al. Application of spyglass^TM DS direct visualization system in the diagnosis and treatment of biliary tract diseases[J]. J Clin Hepatol, 2020, 36(11): 2626-2629. DOI: 10.3969/j.issn.1001-5256.2020.11.052. 徐雯, 苗龙, 王正峰, 等. SpyGlass TM DS直视化系统在胆道疾病诊疗中的应用[J]. 临床肝胆病杂志, 2020, 36(11): 2626-2629. DOI: 10.3969/j.issn.1001-5256.2020.11.052.
[13]	BERNICA J, ELHANAFI S, KALAKOTA N, et al. Cholangioscopy is safe and feasible in elderly patients[J]. Clin Gastroenterol Hepatol, 2018, 16(8): 1293-1299. e2. DOI: 10.1016/j.cgh.2018.02.032.
[14]	GAD EH, ZAKARIA H, KAMEL Y, et al. Surgical (Open and laparoscopic) management of large difficult CBD stones after different sessions of endoscopic failure: A retrospective cohort study[J]. Ann Med Surg (Lond), 2019, 43: 52-63. DOI: 10.1016/j.amsu.2019.05.007.
[15]	WANG HG, TAO LY, GUO QM. Endoscopic retrograde cholangiopancreatography combined with SpyGlass digital system choledochoscope in treatment of gallbladder neck stones and acute cholecystitis[J]. J Surg Concepts Pract, 2020, 25(6): 1-5. DOI: 10.16139/j.1007-9610.2020.06.0. 王宏光, 陶丽莹, 郭庆梅. 内镜逆行胰胆管造影联合SpyGlass DS胆道镜治疗胆囊颈结石和急性胆囊炎[J]. 外科理论与实践, 2020, 25(6): 1-5. DOI: 10.16139/j.1007-9610.2020.06.0.
[16]	MA SR, ZHANG YC, YANG Z, et al. Application of endoscopic retrograde cholangiopancreatography for patients with acute cholecystitis[J]. Chin J Dig Endosc, 2013, 30(5): 269-272. DOI: 10.3760/cma.j.issn.1007-5232.2013.05.008. 麻树人, 张迎春, 杨卓, 等. 内镜逆行胰胆管造影技术在急性胆囊炎患者中的临床应用价值[J]. 中华消化内镜杂志, 2013, 30(5): 269-272. DOI: 10.3760/cma.j.issn.1007-5232.2013.05.008.
[17]	ZHANG H, LIU DQ, XIAO L, et al. ERCP combined with SpyGlass system for the treatment of concomitant gallbladder stones and secondary common bile duct stones in high-risky surgical patients[J]. Chin J Pract Surg, 2018, 38(11): 1310-1313. DOI: 10.19538/j.cjps.issn1005-2208.2018.11.21. 张航, 刘丹青, 肖乐, 等. ERCP联合SpyGlass系统治疗高危胆囊结石合并继发胆总管结石可行性研究[J]. 中国实用外科杂志, 2018, 38(11): 1310-1313. DOI: 10.19538/j.cjps.issn1005-2208.2018.11.21.
[18]	BACA-ARZAGA AA, NAVARRO-CHÁVEZ A, GALINDO-JIMÉNEZ A, et al. Gallstone lithotripsy with SpyGlass^TM system through a cholecystoduodenal fistula in a patient with type Ⅲa Mirizzi syndrome[J]. Rev Gastroenterol Mex (Engl Ed), 2021, 86(1): 99-101. DOI: 10.1016/j.rgmx.2020.01.003.
[19]	HAN W, YUE Q, LIU K, et al. Endoscopic nasogallbladder drainage combined with laparoscopic surgery for type I Mirizzi syndrome with acute cholecystitis: a case series report[J]. Gastroenterol Res Pract, 2020, 2020: 2417539. DOI: 10.1155/2020/2417539.
[20]	ISSA H, BSEISO B, ALMOUSA F, et al. Successful treatment of mirizzi's syndrome using SpyGlass guided laser lithotripsy[J]. Gastroenterology Res, 2012, 5(4): 162-166. DOI: 10.4021/gr447w.

Relative Articles

Supplements(0)

Cited By

Cited by

Periodical cited type(3)

1.	赵远红，陈茂艳，杨瑞雪，吕强. 隐源性肝癌与病毒性肝癌临床特征比较. 中西医结合肝病杂志. 2020(02): 107-110 .
2.	赵远红，吕强，杨瑞雪，陈茂艳. 14例病理诊断明确的隐源性肝癌临床资料分析. 中医肿瘤学杂志. 2020(02): 19-23+38 .
3.	张杨，孙立哲，刘宝刚，耿翠翠，董妙，李磊强，李欣. 颅内血管外皮细胞瘤MRI影像学特征与ki67因子表达相关性研究. 临床军医杂志. 2017(12): 1267-1269 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1) / Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (830) PDF downloads(50)

Efficacy of endoscopic retrograde cholangiopancreatography combined with SpyGlass system in treatment of acute cholecystitis secondary to choledocholithiasis

DOI: 10.3969/j.issn.1001-5256.2022.08.025